Recent News

• 04.16.2025 - RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community
• 04.04.2025 - RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
• 04.01.2025 - RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

Recent Filings

• 04.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.10.2025 - 4 Statement of changes in beneficial ownership of securities